Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Natural product-based therapy for Hepatocellular carcinoma: Asprin [acetylsalicylic acid (ASA)] increases the expression of hepatocellular carcinoma, downregulated 1 (HEPN1) and inhibits the progression of hepatocellular carcinoma via down regulation of its target gene, 24/February/2015, 22.33, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that Asprin [acetylsalicylic acid (ASA) ], by decreasing the expression of its target gene, it may increase the expression of HEPN1. Thereby, it may inhibit the progression of Hepatocellular carcinoma. Thus, pharmacological formulations encompassing “asprin or its analogues” can be used to treat Hepatocellular carcinoma.
Amount: $ 300
Undisclosed information: How aspirin increases the expression of HEPN1
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation